In the present study, following treatment of GC cell lines with the γ-secretase inhibitor DAPT, the expression of the Notch1 target gene, Hes1, was significantly decreased, E-cadherin was upregulated and mesenchymal proteins, such as N-cadherin and vimentin, were downregulated. This evidence concerns the gene NOTCH1 and gastric cancer.